STAT

‘I really don’t know what happened to Jim’: Friends ask where James Watson’s odious attitudes about race came from

Watson saw his double-helix discovery as proof of his view that intuition and opposing the establishment consensus are stronger guides to truth than empirical research.

Even before a documentary on biologist James Watson aired on Wednesday night as part of PBS’s “American Masters” series, social media was aflame with protests from scientists and others about its very existence: After Watson’s many statements denigrating blacks, women, and others, it is more than time for the media to “move on,” one biologist tweeted. Another protested giving oxygen to Watson’s “infuriating” and “unfounded comments about race,” while a biologist at the institution Watson ran for nearly 40 years decried his “racist bull—-” and “the harm it does to our science.”

Watson’s many odious comments over the decades might be blamed on age (he is 90), or irascibility, or a privileged white man’s raging at a world that no longer winks at  like “some anti-Semitism is justified.” But in interviews with STAT, longtime friends offered another explanation for

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks